Where does Mystic Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Mystic Pharmaceuticals, Inc. ranks #36,591 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Mystic Pharmaceuticals, Inc. hold?

Mystic Pharmaceuticals, Inc. holds 7 US utility patents granted between 2016 and 2020, spanning 13 technology areas.

What is Mystic Pharmaceuticals, Inc.'s Innovation Score?

Mystic Pharmaceuticals, Inc. has an Innovation Score of 29.8 out of 100 (32nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Mystic Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Mystic Pharmaceuticals, Inc.'s recent grant velocity is -83% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Mystic Pharmaceuticals, Inc.'s patents?

Mystic Pharmaceuticals, Inc.'s patents average 16.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Mystic Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Mystic Pharmaceuticals, Inc.

Q: What technology areas does Mystic Pharmaceuticals, Inc. focus on?

Mystic Pharmaceuticals, Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 4 patents. Grants appear in 13 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 13 technology areas, recorded in grant years 2016–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Mystic ranks #36,591 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 13 technology areas.

#36,591
of 49,997 US assignees by volume: 32nd percentile
by Innovation Score (29.8/100): 16.4
avg claims per patent: -83%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R36591 · US Corporation #36,591 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #36,591/49,997
PHOTO-FINISH Mycone Dental Supply
CPC-FOCUS A61M · 13 areas
INNOV-THIN 29.8/100
CLAIMS-RICH 16.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -83% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mycone Dental Supply Company, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Mystic Pharmaceuticals · this assignee

30
3D Lighting… · lowest

7

What this shows Mystic's Innovation Score is 29.8/100 (32nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Mystic's grants concentrate

Mystic Pharmaceuticals, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 57.1% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2016 (4 grants) versus a trough of 1 in 2017. By volume, Mystic sits between Mycone Dental Supply Company, Inc. and Naeilhae, Co. Ltd..

Mycone Dental Sup…

7
Mylan Pharmaceuti…

7
Mylan Specialty

7
Myovant Sciences

7
N-fab

7
N-tuple

7
Nacco Materials H…

7
Naeilhae

7
Mystic Pharmaceut… ◀

7

What this shows Mystic holds 7 patents at rank #36,568, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Mystic

By rank, the assignees closest to #36,568 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Mystic's primary technology class.

Mystic's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 32nd percentile higher than 32% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Mystic Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	4	57.1%
2017	1	14.3%
2018	1	14.3%
2020	1	14.3%

Which technologies does Mystic Pharmaceuticals, Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 4

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 3

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

A61B - DIAGNOSIS; SURGERY; Identification 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 1

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 1

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

B21D - Working OR Processing OF Sheet Metal OR Metal Tubes, Rods OR Profiles Without Essentially Removing MATERIAL; Punching Metal 1

Top 13 of 13 technology areas

Where it ranks

Overall rank by patents

#36,591

of 49,997 tracked assignees

Innovation Score

29.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Mystic Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Mystic Pharmaceuticals, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 57.1% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #36,591 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Mystic Pharmaceuticals, Inc. against Mycone Dental Supply Company, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.